CTRI/2019/12/022217CompletedPhase 2
An open labeled interventional clinical trial to evaluate the efficacy of Rhumed strong oil in the management of Osteoarthritis of knee joint.
Multani Pharmaceuticals Ltd New Delhi1 site in 1 country50 target enrollmentStarted: February 12, 2019Last updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Assessment of pain
Study Overview
Brief Summary
It is an open labeled, single armed, single center, prospective, interventional clinical study to evaluate the efficacy of the Rhumed strong oil on 50 patients suffering from osteoarthritis of knee joint. The study will be conducted in Panchakarma department, NIA, Jaipur, Rajasthan. It will be advised to subjects to apply the oil 2 times a day on the affected knee joint/s for 15 days. The primary outcome measure will be to assess the efficacy of Rhumed strong oil in patients of Joints pain by assessing the degree of pain on day 0, day 15 and day 22. The secondary outcome will be assess the changes in swelling, tenderness, stiffness and restricted movement in joint.
Study Design
- Study Type
- Interventional
- Allocation
- Not Applicable
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 40.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Age: from 40-70 years of either sex Subjects with symptoms of Osteoarthritis of knee joint Subjects who are willing to give informed consent any ready to comply the protocol Subjects who are ready to provide regular follow up till the completion of the study.
Exclusion Criteria
- •Patients of age below 40 years and above 70 years of either sex Patients having associated Pulmonary Tuberculosis, Burns, Open wounds and infective conditions, allergy, skin sensitivity , Knee joint replacement, Gouty arthritis, Rheumatoid arthritis etc.
Outcomes
Primary Outcomes
Assessment of pain
Time Frame: one year
Secondary Outcomes
- Changes in the degree of swelling, stiffness, restricted movement of the joints, tenderness and development of any adverse effect(one year)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Study the effect of Sundari Jeevak syrup in Kashtartava (Primary dysmenorrhea)CTRI/2020/01/022673Multani Pharmaceuticals Ltd50
Unknown
Phase 2
Clinical evaluation for the efficacy of Muliv strong syrup in the management of Non- Alcoholic Fatty Liver disease (NAFLD).CTRI/2019/12/022578Multani Pharmaceuticals Ltd50
Completed
Phase 2
Ayurvedic Management of Ajeerna (Indigestion).CTRI/2020/01/022661Multani Pharmaceuticals Ltd50
Not yet recruiting
Phase 2
Study to Evaluate the Efficacy of Afatinib in Skull Base ChordomaChordoma of ClivusNCT05519917Huashan Hospital20
Unknown
Phase 2
Management Madhumeha (Diabetes mellitus type 2)CTRI/2020/01/022662Multani Pharmaceuticals Ltd50